Review
Accepted on 06 Mar 2026
Retiring Legacy Regulatory Requirements in Monoclonal Antibody Development: Toward an Evidence-Efficient, Analytics-First Paradigm
in Technological and Methodological Advances in Drug Delivery
Review
Accepted on 06 Mar 2026
in Technological and Methodological Advances in Drug Delivery
Review
Accepted on 06 Mar 2026
in Inflammation
Methods
Accepted on 06 Mar 2026
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Review
Accepted on 06 Mar 2026
in Viral Immunology
Correction
Accepted on 06 Mar 2026
in Food Microbiology
Original Research
Accepted on 06 Mar 2026
in Infectious Agents and Disease
Review
Accepted on 06 Mar 2026
in Molecular Innate Immunity
Original Research
Accepted on 06 Mar 2026
in Cancer Epidemiology and Prevention
Original Research
Accepted on 06 Mar 2026
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 06 Mar 2026
in Leadership in Education
Original Research
Accepted on 06 Mar 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 06 Mar 2026
in Mental Health and Wellbeing in Education
Original Research
Accepted on 06 Mar 2026
in Sport Psychology
Original Research
Accepted on 06 Mar 2026
in Gastroenterology
Editorial
Accepted on 06 Mar 2026
in Cognition
Review
Accepted on 06 Mar 2026
in Neurocognitive Aging and Behavior